Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

Key players in Japan lupus market have significant scope to improve presence in digital space, says GlobalData

Pharma companies offer support to Japanese patients and rheumatologists with systemic lupus erythematosus (SLE or lupus) through unbranded and branded digital channels providing disease support tools. However, there is a significant opportunity for key players such as GSK and AstraZeneca to improve their presence in the digital space, says GlobalData, a leading data and analytics […]
Read more

Card payments in India to surpass $300bn mark in 2022, says GlobalData

India made remarkable progress in the adoption of digital payments in recent years, supported by government’s push and improvements in payments infrastructure. As a result, the card payments market in India is anticipated to grow by 31.2% in 2022 to reach INR22.3 trillion ($305.4bn), driven by economic recovery post COVID-19 pandemic, widespread vaccination program and […]
Read more

ExxonMobil tops GlobalData list of top 10 most mentioned oil and gas companies on social media in 2021

Oil and gas (O&G) industry is recovering gradually from the impact of the COVID-19 pandemic, which disrupted the supply chain and cratered demand. All the while, shareholders and activists have been putting ever increasing pressure to pledge and act on reducing carbon emissions. Against this backdrop, ‘Exxon Mobil Corporation (ExxonMobil)’ is ranked top among the […]
Read more

Positive phase III data will give Neurocrine’s Ingrezza dominant position in Huntington’s disease market, says GlobalData

Neurocrine Biosciences has recently announced that its pipeline asset, Ingrezza (valbenazine), achieved the primary endpoint of reducing the symptoms of chorea (involuntary muscle movements) associated with Huntington’s disease (HD) in the Phase III clinical trial, KINECT-HD (NCT04102579). This will propel Ingrezza into a dominant position in the HD market, due to its convenient once-daily dosing […]
Read more

Technology Innovation Intensity (TII) for Cybersecurity

The Technologies Innovation Intensity (TII) framework by GlobalData Plc combines diverse alternative datasets to signal the progress of technologies and in the process helps detect key inflection points ahead of time to place the right tech bets at the right time. The signal for Cybersecurity as a technology (dark blue line) in the below infographic shows a 2-year lead and 40% CAGR returns against the thematic […]
Read more

Environmental Sustainability

Environmental innovation, backed by advanced technologies, raises hope for a sustainable future. Here’s an infographic that identifies startups leveraging emerging technologies to offer a range of solutions. This is based on the ‘Innovation Radar – Cleantech 2.0’ report by GlobalData Plc. Read this report and get access to more such intelligence for free here – https://lnkd.in/gT6EVrYq.
Read more

Knee reconstruction market in India to witness 9% growth through 2030, forecasts GlobalData

The knee reconstruction market in India is expected to grow at a compound annual growth rate of about 9% between 2021 and 2030, driven by growing number of trauma cases, rapidly aging population and increasing prevalence of obesity, forecasts GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Knee Reconstruction (Orthopedic Devices) – Global     […]
Read more

Mergers and acquisitions, venture financing to boost healthtech market in Singapore, says GlobalData

Growing awareness on healthcare, research centric ecosystem, favorable regulatory scenario under the Smart Nation initiative and the increased need for digital consultations amidst the COVID-19 pandemic are the factors driving investments in healthtech sector in Singapore, says GlobalData, a leading data and analytics company. GlobalData’s report, ‘Singapore Healthcare, Regulatory and Reimbursement Landscape – CountryFocus’, reveals […]
Read more

Zydus Cadila Desidustat better positioned to get first to market advantage within HIF-PHI class in India, says GlobalData

New class of treatment, especially hypoxia inducible factor prolyl hydroxylase inhibitor (HIF-PHI) to treat patients with anemia from chronic kidney disease (CKD), is gaining traction in countries where drugs of this class are approved. India is yet to approve its first HIF-PH inhibitor drug to treat anemia associated with chronic kidney disease. However, Zydus Cadila’s […]
Read more

Influencers advise close surveillance of travelers against Omicron driven travel ban, finds GlobalData

Several countries across the globe have restarted imposing international travel restrictions and measures to guard against Omicron, a new variant of the COVID-19. However, Twitter influencers and Redditors are of the opinion that travel ban may actually harm many industries, especially the travel and tourism industry, according to the Social Media Analytics Platform of GlobalData, […]
Read more

Advanced materials make noise on Twitter, finds GlobalData

Advanced materials are grabbing the interest of business leaders to create sophisticated products and design new business models. An analysis of the Social Media Analytics platform of GlobalData, a leading data and analytics company, reveals that mentions for advanced materials, especially nanomaterials and smart materials, on Twitter have doubled over the last two years. Sanchari […]
Read more
1 … 148 149 150 151 152 … 209